News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Dan Schell: How can we improve trial site Feasibility Assessments?
Dan Schell/LinkedIn
Apr 4, 2025, 09:16

Dan Schell: How can we improve trial site Feasibility Assessments?

Dan Schell, Chief Editor and Clinical Leader at Life Science Connect, shared a post on LinkedIn:

“In 2021, American Society of Clinical Oncology (ASCO) made the following 3 recommendations to improve trial site feasibility assessments (FAs):

1. implement a streamlined and uniform FA process across trials and sponsors
2. minimize and standardize questions
3. leverage technology to centralize FAs, facilitate communications, and reduce redundancies.

Have we made enough improvements since then?”

ASCO cancer clinical trials Dan Schell OncoDaily Oncology
Special Coverage
Blog
May 2, 2025, 12:03
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support
Blog
May 2, 2025, 11:23
Sanam Loghavi: Hemepath Morphology Challenge
Blog
May 2, 2025, 11:16
Nicole Stout: ASCO Survivorship Community of Practice
Blog
May 2, 2025, 11:11
Cristiane Bergerot: FKSI-23 Measure for RCC is Available on the FACIT Website
Blog
May 2, 2025, 11:09
Society for Integrative Oncology Seeks Input for Potential Research Summit
Blog
May 2, 2025, 11:00
Guillermo Chantada: Current Survival Figure of Retinoblastoma in Argentina according to the National Registry (ROHA)
Blog
May 2, 2025, 10:51
Beau Bosko Toskich: Combining Local Therapy and Immunotherapy in Intermediate Stage HCC
Blog
May 2, 2025, 10:51
Douglas Flora: A Future where Mental Health gets unstuck—and finally starts moving forward
Blog
May 2, 2025, 10:42
ACS CAN cancer advocates attended a Senate Appropriations hearing on biomedical research
Science
May 2, 2025, 10:42
How PLT012 can Rejuvenate Antitumor Immunity by Targeting Metabolic Pathways to Reprogram the Immune landscape of Liver Cancer and Liver Metastasis - Cancer Research Institute
Blog
May 2, 2025, 10:33
Tim Brown: Safety and Efficacy of Liver-Directed Radiation with Atezolizumab-Bevacizumab in Advanced HCC
Blog
May 2, 2025, 10:31
Home Away From Home Phase 2 - Childhood Cancer International